[Latest] Global AI in Drug Repurposing Market Size/Share Worth USD 10.56 Billion by 2035 at a 23.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

The global AI in drug repurposing market is projected to grow from USD 1.28 billion in 2025 to USD 10.56 billion by 2035, at a CAGR of 23.4%. The market is driven by the need to accelerate drug discovery, reduce development costs, and address growing instances of chronic and rare diseases. Key players include BostonGene Corporation, BenevolentAI, Innophore, Delta4.ai, BioXcel Therapeutics, and others. Software platforms dominate the market, with machine learning and natural language processing as leading technologies, while oncology represents the largest application segment.